Receptivity to a Nurse-Led Symptom Management Intervention Among Highly Symptomatic Patients With Cancer.
Journal
Journal of the National Cancer Institute
ISSN: 1460-2105
Titre abrégé: J Natl Cancer Inst
Pays: United States
ID NLM: 7503089
Informations de publication
Date de publication:
08 03 2022
08 03 2022
Historique:
received:
30
04
2021
revised:
09
07
2021
accepted:
08
09
2021
pubmed:
12
9
2021
medline:
23
3
2022
entrez:
11
9
2021
Statut:
ppublish
Résumé
The symptom burden associated with cancer and its treatment can negatively affect patients' quality of life and survival. Symptom-focused collaborative care model (CCM) interventions can improve outcomes, but only if patients engage with them. We assessed the receptivity of severely symptomatic oncology patients to a remote nurse-led CCM intervention. In a pragmatic, cluster-randomized, stepped-wedge trial conducted as part of the National Cancer Institute IMPACT Consortium (E2C2, NCT03892967), patients receiving cancer care were asked to rate their sleep disturbance, pain, anxiety, emotional distress, fatigue, and limitations in physical function. Patients reporting at least 1 severe symptom (≥7/10) were offered phone consultation with a nurse symptom care manager (RN SCM). Initially, patients had to "opt-in" to receive a call, but the protocol was later modified so they had to "opt-out" if they did not want a call. We assessed the impact of opt-in vs opt-out framing and patient characteristics on receptiveness to RN SCM calls. All statistical tests were 2-sided. Of the 1204 symptom assessments (from 864 patients) on which at least 1 severe symptom was documented, 469 (39.0%) indicated receptivity to an RN SCM phone call. The opt-out period (odds ratio [OR] = 1.61, 95% confidence interval [CI] = 1.12 to 2.32, P = .01), receiving care at a tertiary care center (OR = 3.59, 95% CI = 2.18 to 5.91, P < .001), and having severe pain (OR = 1.80, 95% CI = 1.24 to 2.62, P = .002) were associated with statistically significantly greater willingness to receive a call. Many severely symptomatic patients were not receptive to an RN SCM phone call. Better understanding of reasons for refusal and strategies for improving patient receptivity are needed.
Sections du résumé
BACKGROUND
The symptom burden associated with cancer and its treatment can negatively affect patients' quality of life and survival. Symptom-focused collaborative care model (CCM) interventions can improve outcomes, but only if patients engage with them. We assessed the receptivity of severely symptomatic oncology patients to a remote nurse-led CCM intervention.
METHODS
In a pragmatic, cluster-randomized, stepped-wedge trial conducted as part of the National Cancer Institute IMPACT Consortium (E2C2, NCT03892967), patients receiving cancer care were asked to rate their sleep disturbance, pain, anxiety, emotional distress, fatigue, and limitations in physical function. Patients reporting at least 1 severe symptom (≥7/10) were offered phone consultation with a nurse symptom care manager (RN SCM). Initially, patients had to "opt-in" to receive a call, but the protocol was later modified so they had to "opt-out" if they did not want a call. We assessed the impact of opt-in vs opt-out framing and patient characteristics on receptiveness to RN SCM calls. All statistical tests were 2-sided.
RESULTS
Of the 1204 symptom assessments (from 864 patients) on which at least 1 severe symptom was documented, 469 (39.0%) indicated receptivity to an RN SCM phone call. The opt-out period (odds ratio [OR] = 1.61, 95% confidence interval [CI] = 1.12 to 2.32, P = .01), receiving care at a tertiary care center (OR = 3.59, 95% CI = 2.18 to 5.91, P < .001), and having severe pain (OR = 1.80, 95% CI = 1.24 to 2.62, P = .002) were associated with statistically significantly greater willingness to receive a call.
CONCLUSIONS
Many severely symptomatic patients were not receptive to an RN SCM phone call. Better understanding of reasons for refusal and strategies for improving patient receptivity are needed.
Identifiants
pubmed: 34508602
pii: 6368684
doi: 10.1093/jnci/djab172
pmc: PMC8902324
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
458-466Subventions
Organisme : NCI NIH HHS
ID : UM1 CA233033
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA232980
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA233035
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA233080
Pays : United States
Commentaires et corrections
Type : ErratumIn
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press.
Références
BMJ. 2009 Jan 14;338:a3162
pubmed: 19147479
Cancer. 1999 Mar 1;85(5):1186-96
pubmed: 10091805
Chron Respir Dis. 2013 Feb;10(1):35-47
pubmed: 23355404
JAMA. 2014 Jul 16;312(3):240-8
pubmed: 25027139
Support Care Cancer. 2018 Jan;26(1):41-60
pubmed: 28849277
J Clin Oncol. 2016 Feb 20;34(6):557-65
pubmed: 26644527
Cancer. 2000 May 1;88(9):2164-71
pubmed: 10813730
Pilot Feasibility Stud. 2019 Mar 8;5:39
pubmed: 30891308
J Psychosom Res. 2014 Oct;77(4):247-63
pubmed: 25201482
Am J Gastroenterol. 2018 Dec;113(12):1848-1854
pubmed: 29925915
JAMA Psychiatry. 2016 Sep 1;73(9):978-89
pubmed: 27602561
BMC Cancer. 2018 Dec 4;18(1):1203
pubmed: 30514351
Ann Oncol. 2008 Dec;19(12):1985-91
pubmed: 18632721
BMJ. 2002 Nov 16;325(7373):1145
pubmed: 12433764
Arch Phys Med Rehabil. 2017 Feb;98(2):203-210
pubmed: 27592401
Eur J Cancer Care (Engl). 2013 Jan;22(1):70-8
pubmed: 22805171
Support Care Cancer. 2014 Sep;22(9):2343-50
pubmed: 24687538
Cancer. 2000 Oct 1;89(7):1634-46
pubmed: 11013380
J Pain Symptom Manage. 2009 Apr;37(4):715-36
pubmed: 19019626
J Pain Symptom Manage. 2014 Jun;47(6):973-89
pubmed: 24210705
J Pain Symptom Manage. 2015 Sep;50(3):321-7
pubmed: 25975643
Support Care Cancer. 2013 Feb;21(2):537-47
pubmed: 22864472
J Clin Oncol. 2014 Jan 20;32(3):199-205
pubmed: 24344222
BMJ. 2016 Jan 19;532:h6895
pubmed: 26786744
Trials. 2020 Jun 5;21(1):480
pubmed: 32503661
Support Care Cancer. 2013 Jan;21(1):229-33
pubmed: 22915355
Eur J Oncol Nurs. 2007 Jul;11(3):212-23; discussion 224-7
pubmed: 17188938
JAMA Oncol. 2019 May 1;5(5):644-652
pubmed: 30946436
Cancer Med. 2017 Mar;6(3):537-546
pubmed: 28135050
BMC Health Serv Res. 2013 Jun 11;13:211
pubmed: 23758898
J Clin Oncol. 2014 May 10;32(14):1480-501
pubmed: 24711559
Am J Health Promot. 2018 Mar;32(3):745-752
pubmed: 28281353
Health Qual Life Outcomes. 2010 Sep 21;8:104
pubmed: 20858248
Support Care Cancer. 2018 May;26(5):1607-1615
pubmed: 29204710
Psychol Med. 2010 Nov;40(11):1797-810
pubmed: 20085667